Adamis Pharmaceuticals Announces Pricing of $6.7 Million Registered Direct Offering – GlobeNewswireBy / February 21, 2020 Adamis Pharmaceuticals Announces Pricing of $6.7 Million Registered Direct Offering GlobeNewswire Share this:TweetReddit